The Struggles of India’s Vaccine Giant

As Iran has tightened its chokehold on one of the world’s most vital shipping routes and the Trump administration sent mixed signals about how long the war would last, oil prices have swung wildly. Rebecca F. Elliott, who covers energy for The New York Times, explains just how mu ...  Show more

What began as a relentless U.S.-Israeli military assault on Iran has turned into a wider crisis as the disruption of the world’s oil markets spreads beyond the Middle East. Eric Schmitt, a national security correspondent for The New York Times, discusses what we know about the pl ...  Show more

It's time to pay attention! We're not supposed to know about the politicization of lockdown policies, vaccine distribution, schools reopening ... and we're not supposed to say anything about any of it, but this is the time to be watching and taking notice more than ever. -- Today ...  Show more

Thejna John is a happy woman. Last year, the relapse of an acute form of blood cancer despite a bone marrow transplant, had made her doctors give up all hope.

In October, came a breakthrough. India approved the CAR T-Cell therapy, a revolutionary treatment for some form ...

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from ...

Les vaccins contre le Covid-19 sont au centre de toutes les attentions. Ils sont l'espoir auquel se raccrochent les gouvernements du monde entier pour sortir de la crise sanitaire qui nous touche depuis un an. Si leur mise au point s'est faite en un temps record, en matière de ...